C J Li

Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.

C J Li, L J Zhang, Bruce J. Dezube et al. · Proceedings of the National Academy of Sciences · 1993 · 234 citations · Full text

Immunology, Molecular Biology, Antiviral Drug +16

beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin.

C J Li, Lidia Averboukh, Arthur B. Pardee · Journal of Biological Chemistry · 1993 · 217 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Novel Dna Topoisomerase +14

Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1.

C J Li, Chao Wang, David J. Friedman et al. · Proceedings of the National Academy of Sciences · 1995 · 127 citations · Full text

Wild-type P53, Human Retrovirus, Immunology +14

Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virus.

C J Li, Chao Wang, Arthur B. Pardee · Journal of Biological Chemistry · 1994 · 45 citations · Full text

Type 1, Transcriptional Regulation, Hiv-1 Ltr Mutants +13

Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I

J L Zhang, Pranav Sharma, C J Li et al. · Antimicrobial Agents and Chemotherapy · 1997 · 31 citations · Full text

Altered Topoisomerase, Immunology, Antiviral Drug +17